knowledge -WSS

knowledge

author：comprehensive 2025-09-07 17:30:46 - browse：5

The FDA building -- First Opinion coverage from STAT — Adobe

The Food and Drug Administration on Monday approved a gene therapy for metachromatic leukodystrophy, a devastating genetic disorder that eats away at affected children’s neurons.

The medicine, marketed as Lenmeldy, is the first treatment for MLD, which is otherwise fatal. Lenmeldy has to be given before symptoms appear or, in some cases, after the first signs of disease, so it won’t be helpful for many patients living with MLD today. But when given in time, it appears to be near-curative, allowing some children to grow up and attend school with unaffected peers.

Lenmeldy is already marketed in Europe, under the name Libmeldy, and has helped a handful of patients in the U.S. who were treated under compassionate use, as their doctors feared they didn’t have time to wait for approval.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： State Dept. review finds Biden bears some blame for Afghanistan failures
Next article： Senate bill would ban some hospital facility fees

Wikipedia

hotspot

WSS

Bankrupt Pear's prescription app helped MassHealth save money, data suggests

App could help diagnose ear infections more accurately — and at home

Physicians and social media: If you see something, say something?

Stop the failed accountable care organization experiment

Eli Lilly CEO gives to Mike Pence presidential super PAC

Neurocrine congenital adrenal hyperplasia trial succeeds

Wikipedia

knowledge

focus

New air purifier tech could be key to improving indoor air quality

Nurses recount patients attacks

Virginia high school admissions case could be legal follow

Senate bill would ban some hospital facility fees

Jerome Adams on the need for new antivirals for Covid

Stop the failed accountable care organization experiment

DIEP, the 'gold standard' of breast reconstruction, is under threat

Asbestos, a deadly carcinogen, banned by EPA

The high cost of giving birth even with insurance

Covid’s new normal has set in amid another rise in cases

hotspot

Why the drug industry's warnings on the IRA's impact fall short

'A game

Readout Newsletter: Bluebird, CVS, Contineum

Medicare to pay more for cardiac rehab in hospital outpatient clinics

Assistant physicians can help address the primary care shortage

Baby aspirin cuts fat buildup in liver disease patients, in small study

Wikipedia

Wikipedia

hotspot

entertainment